Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/54042, first published .
A Predictive Noninvasive Single-Nucleotide Variation–Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study

A Predictive Noninvasive Single-Nucleotide Variation–Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study

A Predictive Noninvasive Single-Nucleotide Variation–Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study

Nico Seeger   1 ;   Stefan Gutknecht   2 , Dr med ;   Irin Zschokke   3 , Dr med ;   Isabella Fleischmann   3 , Dr med ;   Nadja Roth   3 , Dr med ;   Jürg Metzger   3 , Prof Dr Med ;   Markus Weber   2 , Prof Dr Med ;   Stefan Breitenstein   1 , Prof Dr Med ;   Lukasz Filip Grochola   1 , PD, Dr med

1 Department of Visceral and Thoracic Surgery, Cantonal Hospital of Winterthur, Winterthur, Switzerland

2 Department of Visceral, Thoracic and Cardiovascular Surgery, Triemli Hospital, Zurich, Switzerland

3 Department of General and Visceral Surgery, Cantonal Hospital of Lucerne, Lucerne, Switzerland

Corresponding Author:

  • Lukasz Filip Grochola, PD, Dr med
  • Department of Visceral and Thoracic Surgery
  • Cantonal Hospital of Winterthur
  • Brauerstrasse 15
  • Winterthur, 8401
  • Switzerland
  • Phone: 41 52-266-41-62
  • Email: lukaszfilip.grochola@ksw.ch